INTRAGAM® 10 to replace INTRAGAM® P, commencing February 2017.

The National Blood Authority (NBA) advises a forthcoming change to Australia's domestically produced intravenous immunoglobulin (IVIg) product.

During the first half of 2017, the 10% concentration 'INTRAGAM 10' will be introduced and will eventually replace the current 6% 'INTRAGAM P'.

INTRAGAM 10 will provide lower volume doses for patients compared with the same Ig dose of INTRAGAM P.